SPRINT-MS: A Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects with Progressive Multiple Sclerosis (NN 102)

Grant

Awarded By

Total Award Amount

  • 9460.00

    • Direct Costs

  • 6435.00

    • Sponsor Award Id

    • Contributor

  • John Rinker II   Investigator  
  • Khurram Bashir   Principal Investigator  
  • Louis Nabors M.D.   Investigator  
  • Michael Vaphiades   Investigator  
  • William Meador   Investigator